| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
2'-Deoxy-N2-isopropylguanosine manufacturers
|
| | 2'-Deoxy-N2-isopropylguanosine Basic information |
| Product Name: | 2'-Deoxy-N2-isopropylguanosine | | Synonyms: | 2'-Deoxy-N2-isopropylguanosine;Guanosine, 2'-deoxy-N-(1-methylethyl)- (9CI);2’-Deoxy-N2-isopropylguanosine;(2R,3S,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite | | CAS: | 201528-73-6 | | MF: | C13H19N5O4 | | MW: | 309.32 | | EINECS: | | | Product Categories: | | | Mol File: | 201528-73-6.mol |  |
| | 2'-Deoxy-N2-isopropylguanosine Chemical Properties |
| density | 1.69±0.1 g/cm3(Predicted) | | pka | 9.80±0.20(Predicted) |
| | 2'-Deoxy-N2-isopropylguanosine Usage And Synthesis |
| Uses | 2’-Deoxy-N2-isopropyl guanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2'-Deoxy-N2-isopropylguanosine Preparation Products And Raw materials |
|